CORD-19:68a7101a90454172c91785d8c352f776a82df5d4 / 314223-314453 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"T17137","span":{"begin":0,"end":230},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Studies using genetically altered mice that express IL7R alpha only in the thymus (IL7RTg^IL7R −/− ) show significant neuroprotection in the myelin oligodendrocyte glycoprotein (MOG) 35-55 peptide model of chronic progressive EAE."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T106","span":{"begin":0,"end":230},"obj":"Sentence"}],"text":"Studies using genetically altered mice that express IL7R alpha only in the thymus (IL7RTg^IL7R −/− ) show significant neuroprotection in the myelin oligodendrocyte glycoprotein (MOG) 35-55 peptide model of chronic progressive EAE."}

{"project":"CORD-19-PD-HP","denotations":[{"id":"T711","span":{"begin":226,"end":229},"obj":"Phenotype"}],"attributes":[{"id":"A711","pred":"hp_id","subj":"T711","obj":"http://purl.obolibrary.org/obo/HP_0002383"}],"text":"Studies using genetically altered mice that express IL7R alpha only in the thymus (IL7RTg^IL7R −/− ) show significant neuroprotection in the myelin oligodendrocyte glycoprotein (MOG) 35-55 peptide model of chronic progressive EAE."}

{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T1246","span":{"begin":75,"end":81},"obj":"Body_part"},{"id":"T1247","span":{"begin":141,"end":147},"obj":"Body_part"}],"attributes":[{"id":"A1246","pred":"uberon_id","subj":"T1246","obj":"http://purl.obolibrary.org/obo/UBERON_0002370"},{"id":"A1247","pred":"uberon_id","subj":"T1247","obj":"http://purl.obolibrary.org/obo/UBERON_0000345"}],"text":"Studies using genetically altered mice that express IL7R alpha only in the thymus (IL7RTg^IL7R −/− ) show significant neuroprotection in the myelin oligodendrocyte glycoprotein (MOG) 35-55 peptide model of chronic progressive EAE."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T2047","span":{"begin":52,"end":56},"obj":"Disease"},{"id":"T2048","span":{"begin":90,"end":94},"obj":"Disease"},{"id":"T2049","span":{"begin":226,"end":229},"obj":"Disease"},{"id":"T2028","span":{"begin":52,"end":56},"obj":"Disease"},{"id":"T67539","span":{"begin":90,"end":94},"obj":"Disease"},{"id":"T22353","span":{"begin":226,"end":229},"obj":"Disease"}],"attributes":[{"id":"A28240","pred":"mondo_id","subj":"T2047","obj":"http://purl.obolibrary.org/obo/MONDO_0015701"},{"id":"A2048","pred":"mondo_id","subj":"T2048","obj":"http://purl.obolibrary.org/obo/MONDO_0015701"},{"id":"A2049","pred":"mondo_id","subj":"T2049","obj":"http://purl.obolibrary.org/obo/MONDO_0005134"},{"id":"A2050","pred":"mondo_id","subj":"T2049","obj":"http://purl.obolibrary.org/obo/MONDO_0019956"},{"id":"A2051","pred":"mondo_id","subj":"T2049","obj":"http://purl.obolibrary.org/obo/MONDO_0005156"},{"id":"A81723","pred":"mondo_id","subj":"T2028","obj":"http://purl.obolibrary.org/obo/MONDO_0015701"},{"id":"A78218","pred":"mondo_id","subj":"T67539","obj":"http://purl.obolibrary.org/obo/MONDO_0015701"},{"id":"A59798","pred":"mondo_id","subj":"T22353","obj":"http://purl.obolibrary.org/obo/MONDO_0005134"},{"id":"A36791","pred":"mondo_id","subj":"T22353","obj":"http://purl.obolibrary.org/obo/MONDO_0019956"},{"id":"A53702","pred":"mondo_id","subj":"T22353","obj":"http://purl.obolibrary.org/obo/MONDO_0005156"}],"text":"Studies using genetically altered mice that express IL7R alpha only in the thymus (IL7RTg^IL7R −/− ) show significant neuroprotection in the myelin oligodendrocyte glycoprotein (MOG) 35-55 peptide model of chronic progressive EAE."}